PACTR202010828881019已完成3 期
Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized placebo controlled trial.
Dr Igboke Francis0 个研究点目标入组 176 人开始时间: 2020年10月2日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 176
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •1.Spontaneous labour in booked patients
- •2.Planned vaginal delivery
- •3.Term?pregnancy
- •4.Singleton pregnancy and cephalic presentation
- •5.Parturient who has no contraindication to the use of tranexamic acid
- •6.Informed consent form signed
排除标准
- •1.Women with prior history of thromboembolism/autoimmune/ sickle cell disease
- •2.Women with bleeding disorders
- •3.Patients with renal disease, liver pathology, known cardiovascular disease
- •4.Multiple pregnancy/intra-utero fetal death/previous uterine surgeries
- •5.Patients with chronic hypertension
- •6.Patients with preeclampsia/eclampsia/HELLP syndrome
- •7.Women with antepartum haemorrhage/ruptured uterus
- •8.Patients with varicose veins at increased risk of deep vein thrombosis
- •9.History of epilepsy/seizure
- •10. Episiotomy
研究者
相似试验
进行中（未招募）
1 期
Study to determine tranxamic acid's effect on the bleedings that occurs within the haemorrhagic caesareaHaemorrhagic ceasereanMedDRA version: 18.1Level: LLTClassification code 10036418Term: Postpartum hemorrhageSystem Organ Class: 100000004868EUCTR2015-002499-26-FRCentre Hospitalier Régional et Universitaire de Lille342
进行中（未招募）
1 期
Tranexamic Acid to reduce bleeding in patients treated with new oral anticoagulants undergoing dental extraction (EXTRACT-NOAC)Patients treated with a NOAC, aged 18 years or older undergoing dental extractionEUCTR2017-001426-17-BEniversity Hospitals Leuven (Gasthuisberg)222
招募中
1 期
Tranexamic Acid for reduction of intra- and postoperative TRansfusion requirements in elective Abdominal surgery: randomized controlled trial (TATRA)bleeding and transfusion requirements for major abdominal surgery, i.e., esophagectomy, gastrectomy, colectomy, rectal resection, pancreatic resection, and hepatectomyMedDRA version: 20.1Level: LLTClassification code: 10051536Term: Intraoperative bleeding Class: 10022117CTIS2023-509970-43-01Martin-Luther-Universitaet Halle-Wittenberg850
已完成
3 期
Blood Loss Reduction: Effect of Tranexamic Acid Routes in Different Knee Prosthesis: A Randomized Controlled Trial.Patients with primary osteoarthritis knee scheduled for unilateral primary total knee arthroplasty (TKA)Primary TKA,open-box knee prosthesis,closed-Tranexamic acidTCTR20170618001aresuan university228
进行中（未招募）
1 期
Research about the administration of an intravenous drug (trantexamic acid)in order to reduce the amount of trasnsfusion in patients suffering femur fracture. An experiment involving patients is designed: two groups of patients are created by chance allocation, in one the tranexamic acid is administered and in the other an innert substance. After that we compare the amount of blood cell bags needed.Bleeding in patients suffering femur neck fractureMedDRA version: 20.1Level: LLTClassification code 10053220Term: Hip injurySystem Organ Class: 100000004863EUCTR2018-000528-32-ESConsorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)276